Paul Hargreaves
Corporate Officer/Principal bij SPAGO NANOMEDICAL AB
Profiel
Paul Hargreaves is currently the Chief Development Officer at Spago Nanomedical AB since 2021.
Prior to this, he worked at LEO Pharma.
A as the Head-Global Clinical Operations & Vice President.
Actieve functies van Paul Hargreaves
Bedrijven | Functie | Begin |
---|---|---|
SPAGO NANOMEDICAL AB | Corporate Officer/Principal | 13-09-2021 |
Eerdere bekende functies van Paul Hargreaves
Bedrijven | Functie | Einde |
---|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SPAGO NANOMEDICAL AB | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |